EXP WORLD HOLDINGS INC (EXPI) Stock Fundamental Analysis
NASDAQ:EXPI - Nasdaq - US30212W1009 - Common Stock - Currency: USD
EXPI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 65 industry peers in the Real Estate Management & Development industry. EXPI has a great financial health rating, but its profitability evaluates not so good. EXPI has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year EXPI has reported negative net income.
In the past year EXPI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: EXPI reported negative net income in multiple years.
In the past 5 years EXPI always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -5.44%, EXPI is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
EXPI has a Return On Equity (-10.38%) which is in line with its industry peers.
With an excellent Return On Invested Capital value of 7.69%, EXPI belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EXPI is below the industry average of 5.53%.
The 3 year average ROIC (3.18%) for EXPI is below the current ROIC(7.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.44% | ||
| ROE | -10.38% | ||
| ROIC | 7.69% |
ROA(3y)-1.25%
ROA(5y)5.75%
ROE(3y)-2.62%
ROE(5y)10.13%
ROIC(3y)3.18%
ROIC(5y)7.72%
1.3 Margins
The Operating Margin of EXPI (0.44%) is comparable to the rest of the industry.
EXPI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 7.50%, EXPI is doing worse than 75.38% of the companies in the same industry.
In the last couple of years the Gross Margin of EXPI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.44% | ||
| PM (TTM) | N/A | ||
| GM | 7.5% |
OM growth 3Y-21.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPI is destroying value.
The number of shares outstanding for EXPI has been reduced compared to 1 year ago.
EXPI has more shares outstanding than it did 5 years ago.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
EXPI has an Altman-Z score of 16.15. This indicates that EXPI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of EXPI (16.15) is better than 93.85% of its industry peers.
There is no outstanding debt for EXPI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 16.15 |
ROIC/WACC0.86
WACC8.97%
2.3 Liquidity
EXPI has a Current Ratio of 1.44. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
EXPI has a Current ratio of 1.44. This is comparable to the rest of the industry: EXPI outperforms 49.23% of its industry peers.
EXPI has a Quick Ratio of 1.44. This is a normal value and indicates that EXPI is financially healthy and should not expect problems in meeting its short term obligations.
EXPI's Quick ratio of 1.44 is in line compared to the rest of the industry. EXPI outperforms 52.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 50.00% over the past year.
EXPI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.70%.
The Revenue has been growing by 36.05% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
Revenue 1Y (TTM)6.7%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%11.71%
3.2 Future
The Earnings Per Share is expected to grow by 249.28% on average over the next years. This is a very strong growth
EXPI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.58% yearly.
EPS Next Y678%
EPS Next 2Y249.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.34%
Revenue Next 2Y7.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
EXPI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 50.29, EXPI can be considered very expensive at the moment.
EXPI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXPI is cheaper than 72.31% of the companies in the same industry.
EXPI is valuated expensively when we compare the Price/Forward Earnings ratio to 20.74, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.29 |
4.2 Price Multiples
61.54% of the companies in the same industry are more expensive than EXPI, based on the Enterprise Value to EBITDA ratio.
EXPI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EXPI is cheaper than 92.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.22 | ||
| EV/EBITDA | 40.1 |
4.3 Compensation for Growth
EXPI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXPI's earnings are expected to grow with 249.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y249.28%
EPS Next 3YN/A
5. Dividend
5.1 Amount
EXPI has a Yearly Dividend Yield of 2.17%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.69, EXPI pays a better dividend. On top of this EXPI pays more dividend than 92.31% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.43, EXPI has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
5.2 History
EXPI has been paying a dividend for over 5 years, so it has already some track record.
EXPI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
EXPI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-141.53%
EPS Next 2Y249.28%
EPS Next 3YN/A
8.72
-0.58 (-6.24%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)
Earnings (Next)
Inst Owners42.02%
Inst Owner Change-2.3%
Ins Owners47.41%
Ins Owner Change-1.04%
Market Cap1.33B
Analysts80
Price Target15.05 (72.59%)
Short Float %22.8%
Short Ratio14.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.17% |
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP-141.53%
Div Incr Years3
Div Non Decr Years3
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-84.77%
Min EPS beat(2)-217.65%
Max EPS beat(2)48.1%
EPS beat(4)2
Avg EPS beat(4)-26.79%
Min EPS beat(4)-217.65%
Max EPS beat(4)67.32%
EPS beat(8)3
Avg EPS beat(8)-36.54%
EPS beat(12)4
Avg EPS beat(12)-0.81%
EPS beat(16)7
Avg EPS beat(16)17.21%
Revenue beat(2)1
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-5.29%
Max Revenue beat(2)4.39%
Revenue beat(4)2
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-5.29%
Max Revenue beat(4)4.39%
Revenue beat(8)5
Avg Revenue beat(8)0.14%
Revenue beat(12)6
Avg Revenue beat(12)-1.22%
Revenue beat(16)10
Avg Revenue beat(16)2.18%
PT rev (1m)0%
PT rev (3m)-6.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-150.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-44.57%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 50.29 | ||
| P/S | 0.29 | ||
| P/FCF | 7.22 | ||
| P/OCF | 6.92 | ||
| P/B | 6.47 | ||
| P/tB | 7.32 | ||
| EV/EBITDA | 40.1 |
EPS(TTM)-0.03
EYN/A
EPS(NY)0.17
Fwd EY1.99%
FCF(TTM)1.21
FCFY13.85%
OCF(TTM)1.26
OCFY14.45%
SpS30.05
BVpS1.35
TBVpS1.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.44% | ||
| ROE | -10.38% | ||
| ROCE | 9.73% | ||
| ROIC | 7.69% | ||
| ROICexc | 17.26% | ||
| ROICexgc | 23.3% | ||
| OM | 0.44% | ||
| PM (TTM) | N/A | ||
| GM | 7.5% | ||
| FCFM | 4.02% |
ROA(3y)-1.25%
ROA(5y)5.75%
ROE(3y)-2.62%
ROE(5y)10.13%
ROIC(3y)3.18%
ROIC(5y)7.72%
ROICexc(3y)6.94%
ROICexc(5y)19.71%
ROICexgc(3y)9.39%
ROICexgc(5y)31.84%
ROCE(3y)4.02%
ROCE(5y)9.77%
ROICexcg growth 3Y-5.32%
ROICexcg growth 5YN/A
ROICexc growth 3Y-8.79%
ROICexc growth 5YN/A
OM growth 3Y-21.63%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.52%
GM growth 5Y-2.67%
F-Score5
Asset Turnover11.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 76.52% | ||
| Cap/Sales | 0.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 633.63% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.44 | ||
| Altman-Z | 16.15 |
F-Score5
WACC8.97%
ROIC/WACC0.86
Cap/Depr(3y)91.01%
Cap/Depr(5y)129.15%
Cap/Sales(3y)0.21%
Cap/Sales(5y)0.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.57%
EPS Next Y678%
EPS Next 2Y249.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.7%
Revenue growth 3Y6.6%
Revenue growth 5Y36.05%
Sales Q2Q%11.71%
Revenue Next Year6.34%
Revenue Next 2Y7.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y375.17%
EBIT growth 3Y-16.46%
EBIT growth 5YN/A
EBIT Next Year525.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.72%
FCF growth 3Y-7.69%
FCF growth 5Y29.67%
OCF growth 1Y-8.42%
OCF growth 3Y-8.12%
OCF growth 5Y28.25%